AAAAAA
Results:
1-13
|
Results: 13
Authors:
Buglioni, S
D'Agnano, I
Vasselli, S
Donnorso, RP
D'Angelo, C
Brenna, A
Benevelo, M
Cosimelli, M
Zupi, G
Mottolese, M
Citation: S. Buglioni et al., p53 nuclear accumulation and multiploidy are adverse prognostic factors insurgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy, AM J CLIN P, 116(3), 2001, pp. 360-368
Authors:
Supino, R
Perego, P
Gatti, L
Caserini, C
Leonetti, C
Colantuono, M
Zuco, V
Carenini, N
Zupi, G
Zunino, F
Citation: R. Supino et al., A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line, EUR J CANC, 37(17), 2001, pp. 2247-2256
Authors:
Leonetti, C
Biroccio, A
Benassi, B
Stringaro, A
Stoppacciaro, A
Semple, SC
Zupi, G
Citation: C. Leonetti et al., Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line, CANC GENE T, 8(6), 2001, pp. 459-468
Authors:
Del Bufalo, D
Trisciuoglio, D
Biroccio, A
Marcocci, L
Buglioni, S
Candiloro, A
Scarsella, M
Leonetti, C
Zupi, G
Citation: D. Del Bufalo et al., Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity, J CELL BIOC, 83(3), 2001, pp. 473-483
Authors:
Biroccio, A
Benassi, B
Amodei, S
Gabellini, C
Del Bufalo, D
Zupi, G
Citation: A. Biroccio et al., C-myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells, MOLEC PHARM, 60(1), 2001, pp. 174-182
Authors:
Biroccio, A
Benassi, B
D'Agnano, I
D'Angelo, C
Buglioni, S
Mottolese, M
Ricciotti, A
Citro, G
Cosimelli, M
Ramsay, RG
Calabretta, B
Zupi, G
Citation: A. Biroccio et al., c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer - Clinical and experimental findings, AM J PATH, 158(4), 2001, pp. 1289-1299
Authors:
Biroccio, A
Candiloro, A
Mottolese, M
Sapora, O
Albini, A
Zupi, G
Del Bufalo, D
Citation: A. Biroccio et al., Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line, FASEB J, 14(5), 2000, pp. 652-660
Authors:
Turco, A
Scarpa, S
Coppa, A
Baccheschi, G
Palumbo, C
Leonetti, C
Zupi, G
Colletta, G
Citation: A. Turco et al., Increased TGF beta type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells, EXP CELL RE, 255(1), 2000, pp. 77-85
Authors:
Putney, SD
Brown, J
Cucco, C
Lee, R
Skorski, T
Leonetti, C
Geiser, T
Calabretta, B
Zupi, G
Zon, G
Citation: Sd. Putney et al., Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide, ANTISENSE N, 9(5), 1999, pp. 451-458
Authors:
Leonetti, C
Biroccio, A
Candiloro, A
Citro, G
Fornari, C
Mottolese, M
Del Bufalo, D
Zupi, G
Citation: C. Leonetti et al., Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotidesin a human metastatic melanoma inherently resistant to cisplatin, CLIN CANC R, 5(9), 1999, pp. 2588-2595
Authors:
Biroccio, A
Del Bufalo, D
Ricca, A
D'Angelo, C
D'Orazi, G
Sacchi, A
Soddu, S
Zupi, G
Citation: A. Biroccio et al., Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule, GENE THER, 6(6), 1999, pp. 1064-1072
Authors:
Buglioni, S
D'Agnano, I
Cosimelli, M
Vasselli, S
D'Angelo, C
Tedesco, M
Zupi, G
Mottolese, M
Citation: S. Buglioni et al., Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and Bcl-2, INT J CANC, 84(6), 1999, pp. 545-552
Authors:
Biroccio, A
Del Bufalo, D
Fanciulli, M
Bruno, T
Zupi, G
Floridi, A
Citation: A. Biroccio et al., bcl-2 inhibits mitochondrial metabolism and lonidamine-induced apoptosis in adriamycin-resistant MCF7 cells, INT J CANC, 82(1), 1999, pp. 125-130
Risultati:
1-13
|